BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 20600582)

  • 1. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.
    Liu B; Tan W; Barsoum A; Gu X; Chen K; Huang W; Ramsay A; Kolls JK; Schwarzenberger P
    Exp Hematol; 2010 Oct; 38(10):877-884.e1. PubMed ID: 20600582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
    Day KV; Li D; Liu S; Guo M; O'Malley BW
    Laryngoscope; 2001 May; 111(5):801-6. PubMed ID: 11368071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
    Wells JW; Darling D; Farzaneh F; Galea-Lauri J
    Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
    Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
    Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen inhibition of EAE involves effects on dendritic cell function.
    Liu HY; Buenafe AC; Matejuk A; Ito A; Zamora A; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2002 Oct; 70(2):238-48. PubMed ID: 12271473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of macrophage colony-stimulating factor mobilized both CD11b+CD11c+ cells and NK1.1+ cells into peripheral blood.
    Misawa E; Sakurai T; Yamada M; Tamura Y; Motoyoshi K
    Int Immunopharmacol; 2004 Jun; 4(6):791-803. PubMed ID: 15135320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells induced in the presence of GM-CSF and IL-5.
    Yi H; Zhang L; Zhen Y; He X; Zhao Y
    Cytokine; 2007 Jan; 37(1):35-43. PubMed ID: 17382554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain.
    Mausberg AK; Jander S; Reichmann G
    Glia; 2009 Sep; 57(12):1341-50. PubMed ID: 19229994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
    Eksioglu EA; Mahmood SS; Chang M; Reddy V
    Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
    Tai KF; Chen PJ; Chen DS; Hwang LH
    J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
    Ebihara S; Endo S; Ito K; Ito Y; Akiyama K; Obinata M; Takai T
    J Biochem; 2004 Sep; 136(3):321-8. PubMed ID: 15598888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.
    Pulendran B; Dillon S; Joseph C; Curiel T; Banchereau J; Mohamadzadeh M
    Eur J Immunol; 2004 Jan; 34(1):66-73. PubMed ID: 14971031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs.
    Vremec D; Lieschke GJ; Dunn AR; Robb L; Metcalf D; Shortman K
    Eur J Immunol; 1997 Jan; 27(1):40-4. PubMed ID: 9021996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
    Gupta V; Singh SM
    Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.